OXYRANE UK
Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.
OXYRANE UK
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxyrane.com
Total Employee:
11+
Status:
Active
Contact:
44 1612 326 000
Email Addresses:
[email protected]
Total Funding:
26.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Current Advisors List
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series D - Oxyrane UK
Morningside Group
Morningside Group investment in Series D - Oxyrane UK
New Science Ventures
New Science Ventures investment in Series D - Oxyrane UK
Official Site Inspections
http://www.oxyrane.com Semrush global rank: 5.36 M Semrush visits lastest month: 1.56 K
- Host name: 104.21.58.205
- IP address: 104.21.58.205
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Oxyrane UK"
Oxyrane UK - Crunchbase Company Profile & Funding
Organization. Oxyrane UK . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Oxyrane …See details»
Oxyrane , Ltd. Information - RocketReach
Oxyrane is a private company with operations in Manchester, UK and Gent, Belgium. It is backed by top-tier venture capital investors, New Science Ventures (New York) and Forbion Capital …See details»
Oxyrane - Products, Competitors, Financials, Employees, …
Oxyrane is a biopharmaceutical company specializing in the development of enhanced enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases, particularly …See details»
Oxyrane - VentureRadar
Oxyrane develops enzyme replacement therapies (ERT) for lysosomal storage diseases (LSDs). Using a proprietary, glycoengineered yeast platform, Oxyrane produces human lysosomal …See details»
Oxyrane 2025 Company Profile: Valuation, Funding
Oxyrane General Information Description. Developer of an enzyme replacement therapy designed to provide treatment of lysosomal storage diseases. The …See details»
Oxyrane Company Profile - Office Locations, Competitors ... - Craft
Oxyrane is a company developing enhanced enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases, with a focus on the diseases of the central nervous …See details»
Oxyrane | Forbion
Www.oxyrane.com Suite 313, Piccadilly House, 49 Piccadilly Manchester M1 2AP United Kingdom Worked on by. Sander Slootweg, MSc Managing Partner. Sander is Managing Partner and co-founded ABN AMRO Capital Life …See details»
Oxyrane UK - Funding, Financials, Valuation & Investors
Oxyrane UK is a biopharmaceutical company developing biosuperior enzyme replacement therapies to treat inherited diseases. Search Crunchbase. ... How much funding has this …See details»
OXYRANE UK LIMITED overview - Find and update company …
Charges for OXYRANE UK LIMITED (05778832) More for OXYRANE UK LIMITED (05778832) Registered office address Merchants House, 21 Merchants Quay, Salford, England, M50 3XF . …See details»
Oxyrane UK Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Oxyrane UK Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Nervous System Diseases, Endocrinology and ...See details»
Oxyrane, Ltd.:Company Profile & Technical Research,Competitor …
Oxyrane, Ltd. has a total of 54 patents . Login to view all basic info. Data Snapshot. 54. Patent. 25. News. High Related Markets. Mentioned companies in the market reports of major market …See details»
Oxyrane - Overview, News & Similar companies | ZoomInfo.com
Jun 30, 2021 View Oxyrane (www.oxyrane.com) location in Lancashire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Oxyrane Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Oxyrane. See Oxyrane company profile and funding data.See details»
Oxyrane - Company Profile - Tracxn
Jan 18, 2025 Oxyrane - Enzyme replacement therapies (ERT) to treat lysosomal storage diseases.. Raised a total funding of $76M over 2 rounds from 4 investors. Founded by Charles …See details»
Oxyrane UK - Contacts, Employees, Board Members, Advisors
Organization. Oxyrane UK . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
News - Oxyrane
Jan 7, 2021 Oxyrane announces the award of a grant by Michael J. Fox Foundation for Parkinson’s research Gent, BELGIUM – July 15, 2018 – Oxyrane, a private biotechnology …See details»
Oxyrane Management Team - CB Insights
Explore {Oxyrane's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Oxyrane CEO, Founder, Key …See details»
Oxyrane | CipherBio
Explore Oxyrane's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Oxyrane Raises $26.5M to Take Lead Enzyme Replacement …
Nov 17, 2011 Enzyme replacement therapies (ERT) firm Oxyrane raised $26.5 million in a series D round of financing. Participants in the fundraising round included Forbion Capital Partners, …See details»
Bioasis Technologies Inc. and Oxyrane UK Ltd. enter into a
Jun 30, 2021 About Oxyrane Oxyrane is a venture funded, pre-clinical stage biotech company dedicated to developing Enzyme Replacement Therapies (ERTs) for Lysosomal Storage …See details»